Kinuya S, Yokoyama K, Konishi S, Tonami N, Hisada K
Department of Nuclear Medicine, Kanazawa University School of Medicine, Ishikawa, Japan.
Nucl Med Biol. 1996 Feb;23(2):137-40. doi: 10.1016/0969-8051(95)02040-3.
We investigated whether induced hypertension could enhance tumor uptake of monoclonal antibody. 111In-DTPA-A7 (IgG1 against 40kD tumor associated glycoprotein) was injected into colon carcinoma xenografted mice which were subcutaneously implanted with micro-osmotic pump containing angiotensin II (AT-II). Biodistribution was observed in groups of mice infused with AT-II at rate of 0.5 micrograms/kg/min (L) or 1 microgram/kg/min (H) and compared with a group of mice infused with saline (S). Tumor uptake of 111In-A7 in L and H was 1.32 and 1.57 times greater than S at 48 h after intravenous injection of A7. Normal organ uptakes also tended to be increased by AT-II infusion. Further study is needed to get optimum effect of hypertensive treatment on biodistribution of radiolabeled MoAb.
我们研究了诱导性高血压是否能增强单克隆抗体的肿瘤摄取。将111铟-二乙三胺五乙酸-A7(针对40kD肿瘤相关糖蛋白的IgG1)注入皮下植入含血管紧张素II(AT-II)微渗透泵的结肠癌异种移植小鼠体内。观察了以0.5微克/千克/分钟(L组)或1微克/千克/分钟(H组)的速率注入AT-II的小鼠组的生物分布情况,并与注入生理盐水的小鼠组(S组)进行比较。静脉注射A7后48小时,L组和H组中111铟-A7的肿瘤摄取量分别比S组高1.32倍和1.57倍。注入AT-II也倾向于使正常器官摄取量增加。需要进一步研究以获得高血压治疗对放射性标记单克隆抗体生物分布的最佳效果。